Patients with testicular cancer had fewer venous access-related complications and overall thrombotic events when first-line chemotherapy was delivered via peripheral intravenous access compared with ...
Racial and Ethnic Inequities at the Practice and Physician Levels in Timely Next-Generation Sequencing for Patients With Advanced Non–Small-Cell Lung Cancer Treated in the US Community Setting We ...
A recent study published in the Journal of the American Medical Association found that short-term vasopressor use via ...
Dublin, Sept. 19, 2022 (GLOBE NEWSWIRE) -- The global sales of intravenous equipment is currently valued at US$ 12.3 billion and is predicted to reach US$ 16.1 billion by 2027, says Fact.MR, a market ...
Orlando, FL - Investigators for the Limbs International Medical Buflomedil (LIMB) trial group believe they have the first proof that buflomedil (Fonzylane®, Cephalon), a vasoactive agent, can reduce ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results